C. Frederiksen

Changes in plasma TIMP-1 levels after resection for primary colorectal cancer.

H. Nielsen, N. Brünner, I. Christensen, 2009, Anticancer research.

Assessment of the Biological Variation of Plasma Tissue Inhibitor of Metalloproteinases-1

H. Nielsen, N. Brünner, I. Christensen, 2008 .

Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1.

H. Nielsen, I. Christensen, M. Blankenstein, 2008, The International journal of biological markers.

Tissue inhibitor of metalloproteinase‐1 levels in plasma from tumour arteries and veins of patients with rectal cancer

H. Nielsen, N. Brünner, I. Christensen, 2007, Scandinavian journal of clinical and laboratory investigation.

Plasma tissue inhibitor of metalloproteinases-1 as a biological marker? Pre-analytical considerations.

H. Nielsen, N. Brünner, I. Christensen, 2007, Clinica chimica acta; international journal of clinical chemistry.

TIMP-1 as a Prognostic Marker in Colorectal Cancer

H. Nielsen, N. Brünner, A. F. Lomholt, 2008 .

Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer.

H. Nielsen, N. Brünner, I. Christensen, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): A novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection

N. Brünner, S. Laurberg, Hans Jørgen Nielsen, 2008, Scandinavian journal of gastroenterology.

Changes in plasma TIMP-1 levels after resection for primary colorectal cancer.

N. Brünner, I. Christensen, A. F. Lomholt, 2009, Anticancer Research.